Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T14:59:23.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page content remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T14:47:26.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page. Its footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T15:50:34.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Now the page displays a 403 Forbidden error, blocking access to the study record instead of showing the study details. This indicates an access-control issue rather than an update to the study information.
    Difference
    17%
    Check dated 2026-09-19T19:06:06.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page updates its version label from v3.6.5 to v3.6.6, representing a small site update without changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-29T19:13:18.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4. This appears to be a small site update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T22:38:12.000Z thumbnail image

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.